Skip to contentClarengateINTELLIGENCE
Companies/06410308

Circassia Pharma Limited

Company profile

DissolvedUnited Kingdom
Register Ask analyst

Financial position

Accounts to 2018-12-31 · GBP

Net assets
£2,288
Cash
—
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
£2,288
Equity
£2,288
Average employees
Not available

Balance-sheet trend

GBP · unknown

Two periods with a known, matching scope are needed for a trend.

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

8 periods
Reported figures2018-12-312017-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Balance sheet
Net assets£2,288£2,288−£2,302,421−£2,033,337−£1,566,795−£1,066,216−£987,030−£624,713
Equity£2,288£2,288−£2,302,421−£2,033,337−£1,566,795−£1,066,216−£987,030−£624,713
Assets
Fixed assets——£0£106,791£106,791£106,791£0—
Current assets——£27,303£104,384£17,215£1£1£19,567
Debtors——£27,303£104,384£17,215£1£1£19,567
Liabilities
Creditors within one year£2,288£2,288£21,601£154,330————
Creditors after one year——£2,308,123£2,090,182————
Net current assets£2,288£2,288£5,702−£49,946−£67,534−£34,629£1−£180,864
Assets less current liabilities£2,288£2,288£5,702£56,845£39,257£72,162£1−£180,864
Source evidenceView filing View filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Register status requires review: Dissolved.

Phoenix signals

Companies sharing directors across a closure — possible restarts

1 link
Cs Pharmaceuticals Limited
1 director continued here after this company closed · 314 days apart · 64% name match
43%

No charges available in our records.